Wellinks secures $10m for respiratory disease RPM tool’s advancement

Wellinks Raises $10M to Scale Predictive Cardiopulmonary RPM

What You Should Know New Haven-based cardiopulmonary digital health provider Wellinks closed a $10M first tranche of its Series B funding round.The financing was led by strategic partner UMass Memorial Health alongside participation from existing inside investors.Wellinks’ FDA-cleared Spire Remote Patient Monitoring (RPM) System and proprietary Health Tags deliver passive, continuous physiological tracking to predict clinical deterioration up to…

Wellinks secures $10m for respiratory disease RPM tool’s advancement

Wellinks has raised $10m to advance its remote patient monitoring (RPM) tool for chronic respiratory disease management. The first close of the company's Series B financing round was led by the University of Massachusetts' Memorial Health (UMMH) and internal investors. Wellinks' lead product is…